Probability of overall response for patients with somatic mutations in Arm A and Arm B. Effect of mutational status on overall response based on combination treatment with azacitidine and durvalumab vs azacitidine monotherapy. The x-axis presents the odds ratio (circles) with 80% CIs (error bars) for overall response and the y-axis presents the genes of interest.